多发性硬化驱动的代谢改变在诱导多能干细胞来源的星形胶质细胞中得到重现
研究从3例多发性硬化患者和3例未受影响对照者获得诱导多能干细胞来源的星形胶质细胞,进行电子显微镜、流式细胞术、细胞因子和谷氨酸测定、基因表达、原位呼吸和代谢组学分析,并用单核RNA测序数据集验证。发现多发性硬化星形胶质细胞存在神经退行性相关基因富集、线粒体分裂增加、超氧化物和促炎趋化因子产生增加、谷氨酸摄取受损和释放增强、电子传递能力和质子漏增加以及氨基酸分解代谢缺陷和鞘脂代谢增加的独特代谢谱。
要点
- 多发性硬化患者来源的诱导多能干细胞星形胶质细胞显示神经退行性相关基因富集。
- 多发性硬化星形胶质细胞线粒体分裂增加,超氧化物和促炎趋化因子产生增加。
- 多发性硬化星形胶质细胞谷氨酸摄取受损、释放增强,并存在氨基酸分解代谢缺陷和鞘脂代谢增加。
核心结论
- 研究描述了多发性硬化患者诱导多能干细胞来源星形胶质细胞的代谢谱,并验证该模型可作为研究疾病机制和进行体外非侵入性药物靶向试验的有力工具。
- 研究发现重现了患者中描述的多个疾病特征,并为多发性硬化星形胶质细胞的代谢重编程提供了新的机制见解,未来治疗研究或可靶向这些改变。
研究设计与样本
- 研究获得并表征了来自3例多发性硬化患者和3例未受影响对照者的诱导多能干细胞来源星形胶质细胞。
- 研究进行了电子显微镜、流式细胞术、细胞因子和谷氨酸测定、基因表达、原位呼吸和代谢组学分析。
- 研究使用单核RNA测序数据集验证了发现。
主要发现
- 多发性硬化星形胶质细胞显示神经退行性相关基因富集。
- 多发性硬化星形胶质细胞线粒体分裂增加。
- 多发性硬化星形胶质细胞超氧化物和与多发性硬化相关的促炎趋化因子产生增加。
- 多发性硬化星形胶质细胞谷氨酸摄取受损和释放增强。
- 多发性硬化星形胶质细胞电子传递能力和质子漏增加,与氧化应激增加一致,并呈现氨基酸分解代谢缺陷和鞘脂代谢增加的独特代谢谱。
临床怎么用
- 作者认为该模型是研究疾病机制和进行体外非侵入性药物靶向试验的非常有力的工具。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Astrocytes play a significant role in the pathology of multiple sclerosis (MS). Nevertheless, for ethical reasons, most studies in these cells were performed using the Experimental Autoimmune Encephalomyelitis model. As there are significant differences between human and mouse cells, we aimed here to better characterize astrocytes from patients with MS (PwMS), focusing mainly on mitochondrial function and cell metabolism. METHODS: We obtained and characterized induced pluripotent stem cell (iPSC)-derived astrocytes from three PwMS and three unaffected controls, and performed electron microscopy, flow cytometry, cytokine and glutamate measurements, gene expression, in situ respiration, and metabolomics. We validated our findings using a single-nuclei RNA sequencing dataset. RESULTS: We detected several differences in MS astrocytes including: (i) enrichment of genes associated with neurodegeneration, (ii) increased mitochondrial fission, (iii) increased production of superoxide and MS-related proinflammatory chemokines, (iv) impaired uptake and enhanced release of glutamate, (v) increased electron transport capacity and proton leak, in line with the increased oxidative stress, and (vi) a distinct metabolic profile, with a deficiency in amino acid catabolism and increased sphingolipid metabolism, which have already been linked to MS. INTERPRETATION: Here we describe the metabolic profile of iPSC-derived astrocytes from PwMS and validate this model as a very powerful tool to study disease mechanisms and to perform non-invasive drug targeting assays in vitro. Our findings recapitulate several disease features described in patients and provide new mechanistic insights into the metabolic rewiring of astrocytes in MS, which could be targeted in future therapeutic studies. ANN NEUROL 2022;91:652-669.
引用
- Ghirotto B, Oliveira DF, Cipelli M, et al. MS-Driven Metabolic Alterations Are Recapitulated in iPSC-Derived Astrocytes. Ann Neurol. 2022. PMID: 35226368. doi:10.1002/ana.26336
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。